{"id":"W4411732515","doi":"10.1093/bjd/ljaf085.133","title":"P105 Lebrikizumab improves quality of life and wellbeing of patients with moderate-to-severe atopic dermatitis inadequately controlled with or ineligible for ciclosporin: German extension results (week 76) of the ADvantage study","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ciclosporin; Atopic dermatitis; Medicine; German; Quality of life (healthcare); Dermatology; Internal medicine; Transplantation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006561627,0.0003444014,0.0006015985,0.0001158263,0.0001092417,0.0003340132,0.0001857965,0.0002372122,0.001694209],"category_scores_gemma":[0.0004496524,0.00009898835,0.0006712168,0.0001327573,0.0001642929,0.000215633,0.0001963464,0.0004696731,0.0001563516],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002337096,"about_ca_system_score_gemma":0.0001866097,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003969366,"about_ca_topic_score_gemma":0.0008190649,"domain_scores_codex":[0.9997885,0.0001136028,0.00001651414,0.00002269796,0.0000240394,0.00003465796],"domain_scores_gemma":[0.9997249,0.00006376048,0.00009207208,0.00002160321,0.00002029232,0.0000772657],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6731161,0.01412443,0.09473965,0.001230356,0.002170675,0.0004723565,0.0002023891,0.0007679437,0.03963504,0.0001581247,0.004093654,0.1692894],"study_design_scores_gemma":[0.163161,0.2890809,0.5339073,0.0001623894,0.00197786,0.0007760044,0.0002093558,0.001412767,0.004704398,0.000107345,0.004457555,0.00004314441],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976841,0.001489851,0.00003240859,0.00006245722,0.00001840089,0.00006636786,0.0001700508,0.000005384552,0.0004709569],"genre_scores_gemma":[0.9990309,0.0003153801,0.0000845087,0.00008968458,0.00002145673,0.00003411404,0.0002463789,8.315979e-7,0.0001767395],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001694209,"threshold_uncertainty_score":0.005667686,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01414657506990698,"score_gpt":0.2923844091531926,"score_spread":0.2782378340832856,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}